Location History:
- Chita-gun, JP (2009 - 2011)
- Aichi, JP (2015 - 2019)
Company Filing History:
Years Active: 2009-2019
Title: Toyoharu Numata: Innovator in Pharmaceutical Chemistry
Introduction
Toyoharu Numata, an accomplished inventor based in Aichi, Japan, has made significant contributions to the field of pharmaceutical chemistry through his innovative patent work. With a remarkable portfolio of five patents, Numata continues to influence the industry with his advancements in polymorph forms and derivative salts.
Latest Patents
Numata's latest inventions include the development of novel crystal forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. This patent explores several polymorph forms—Polymorph Form I, II, III, IV, V, and VI—and details processes for their preparation and uses. Additionally, he has patented various salt forms of this compound, including HCl-salt, HBr-salt, p-toluenesulfonate salt, and ethanedisulfonate salt. His research also includes a method for treating disease conditions mediated by 5-HT4 receptor activity, showcasing the practical application of his inventions in medical treatment.
Career Highlights
Throughout his career, Toyoharu Numata has played pivotal roles in prominent companies such as Raqualia Pharma Inc. and Askat Inc. His innovative mindset and dedication to research have led to breakthroughs that significantly enhance therapeutic options for patients.
Collaborations
Numata has collaborated with esteemed colleagues like Masaki Sudo and Yoshiyuki Okumura, further enriching his research and patent endeavors. These collaborations have contributed to the development of effective pharmaceutical solutions and highlighted the power of teamwork in driving innovation.
Conclusion
Toyoharu Numata stands out as a notable inventor in the realm of pharmaceutical innovations. With his extensive patent portfolio and collaborations, he exemplifies the impact that dedicated inventors can have on the healthcare industry. His work continues to advance our understanding of medicinal compounds and their potential uses in treating various health conditions.